These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Notes on the development of plasma derivatives in the Netherlands. Krijnen HW Vox Sang; 1972; 23(1):32. PubMed ID: 5081012 [No Abstract] [Full Text] [Related]
11. Letter: Safety of SPPS BOTTLES. Lane WR Med J Aust; 1973 Oct; 2(14):707. PubMed ID: 4758178 [No Abstract] [Full Text] [Related]
15. Round table discussion on regulatory and other problems, including hepatitis, in the development of plasma derivatives. Vox Sang; 1972; 23(1):72-9. PubMed ID: 5081017 [No Abstract] [Full Text] [Related]
17. Studies of proteinemia and blood protein fractions in infantile dystrophy. II. Effect of treatment with blood and plasma transfusions, protein hydrolysates and desoxycorticosterone. BACIU I; MIHALCA E; ROSENFELD E; MARGINEANU O; ROMAN M; BRODI G; BARNA V Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane; 1956; 8(4):943-58. PubMed ID: 13500003 [No Abstract] [Full Text] [Related]
18. [Transfusion of blood and blood derivatives. Immunological bases and indications]. Janot C Rev Prat; 1994 Dec; 44(19):2639-45. PubMed ID: 7855535 [No Abstract] [Full Text] [Related]
19. [The physiology of blood and nursing priorities in a blood transfusion: a really special kind of fluid]. Przywara A Pflege Z; 2009 Aug; 62(8):458-61. PubMed ID: 19728435 [No Abstract] [Full Text] [Related]
20. [Risk of immunization to blood cells and diagnostic and therapeutic implications]. Kiefel V Beitr Infusionsther; 1993; 31():44-51. PubMed ID: 7693263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]